Clearside Biomedical Inc at Stifel Healthcare Conference Transcript
So good morning, everyone, and welcome to the Clearside Biomedical presentation. I'm Annabel Samimy, a biopharma analyst at Stifel. And it's our pleasure to have CEO, George Lasezkay here today with us as well as Tom Ciulla, Chief Medical Officer. So why don't we just start by kicking it off with a five-minute overview to get everyone on the same page.
Sure. Thanks, Annabel. And it's great to be here. Appreciate the time. Appreciate the invite, and we're happy to be here. You've been with us a long time.
A little bit, yeah.
And you've been with us a long time. But if you go back, what we've been trying to do at the company for a number of years is come up with a way that's safe, repeatable, and in-office procedure to administer drugs into the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |